Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study: Safety and Therapeutic Dose of a Miltefosine Gel (G-MTF) in Patients With Uncomplicated Cutaneous Leishmaniasis (NCCL)

NCT07149753 is registered in ClinicalTrials.gov with Universidad Industrial de Santander as lead sponsor.

NCT NCT07149753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07149753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study: Safety and Therapeutic Dose of a Miltefosine Gel (G-MTF) in Patients With Uncomplicated Cutaneous Leishmaniasis (NCCL)
Lead sponsor
Universidad Industrial de Santander
Phase
Phase 1
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
August 30, 2026
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous leishmaniasis, cutaneous leishmaniasis, american, topical administration